Amirpasha Moetazedian Presents ARTEMIS: ARTificial Blood Vessels for Thrombosis, Endothelial Modelling, And In Vitro Simulation
Amirpasha Moetazedian, Lecturer in Medical Engineering at University of Hull, shared on LinkedIn:
”Finally able to share this — it’s been a long time coming!
Delighted that our £3 million MRC Research Cluster grant has been awarded for “ARTEMIS: ARTificial Blood Vessels for Thrombosis, Endothelial Modelling, And In Vitro Simulation.”
Kudos to Simon Calaminus for putting this together and leading the Cluster.
I’ll be leading the engineering workpackage for the artificial blood vessels and serving as Deputy Lead for the ARTEMIS, working closely with our fantastic colleagues and collaborators in the UK and US.
We’ll be recruiting! Watch out for several postdoc roles, including a 4-year Postdoc in my lab focused on engineering and validating the artificial vessel platform.
Can’t wait to get started with this team!
Watch this space!”
Stay updated with Hemostasis Today.
-
Jul 13, 2026, 15:23Akshat Jain: 5 Key Clinical Takeaways from ISTH 2026
-
Jul 13, 2026, 15:15Alfonso J. Tafur: Insights on Periprocedural DOAC Management in Atrial Fibrillation at
-
Jul 13, 2026, 14:42Bruno Pougault: The Global Momentum Behind Innovation in Thrombosis and Hemostasis
-
Jul 13, 2026, 14:34Julie Vassart: Optimizing DOAC Detection in an Evolving Anticoagulant Landscape at ISTH 2026
-
Jul 13, 2026, 13:57Heghine Khachatryan: The Diagnostic Dilemma of Non-Criteria Obstetric APS
-
Jul 13, 2026, 13:49Mitra Najafi: Translating Years of Innovation into Global Scientific Dialogue at ISTH 2026
-
Jul 13, 2026, 13:2810 Posts Not To Miss from ISTH 2026, Part 2
-
Jul 13, 2026, 11:25Luisa Müller: Advancing Anticoagulation Strategies for VITT at ISTH 2026
-
Jul 13, 2026, 10:49Joshua Zeidner: Advancing Menin Inhibitor Therapy in MD Education AML-ALL US Focus 2026